Web29 nov. 2024 · Drug: Iodixanol Drug: Iopamidol: Patient Comfort and Safety: GE Healthcare i3 Statprobe: May 2011: Phase 4: NCT00209417 Terminated: Drug: … WebVISIPAQUE (GE Healthcare), VISIPAQUE (GE Healthcare), VISIPAQUE (GE Healthcare) Formula: C35H44I6N6O15. Exact mass: 1549.7133. Mol weight: 1550.1819. Structure: Mol file KCF file DB search: ... D01474 Iodixanol (JAN/USP/INN) Therapeutic category of drugs in Japan [BR:br08301] 7 Agents not mainly for therapeutic purpose
Visipaque 320 - Wirkung, Nebenwirkungen, Dosierung - medikamio
Web12 mei 2024 · GE Healthcare’s intravenous radiographic contrast agents iodixanol and iohexol are currently in shortage due to a COVID-19-related shutdown in China.In an … Web30 mrt. 2007 · Iodixanol is a contrast agent used during coronary angiography, particularly in patients with renal dysfunction. Online. Browse. Drugs. Starred Drugs ... GE Healthcare Inc. 2010-06-01: Not applicable: US: Visipaque: Injection, solution: 270 mg/1mL: Intravascular: GE Healthcare Inc. 2002-12-13: Not applicable: US: Visipaque 270: optima nanotech golf balls
Iodixanol IODIXANOL 270 mg/mL FRESENIUS KABI USA, LLC
WebGE Healthcare #00407222317 Visipaque™ Iodixanol 320 mg / mL Injection Bottle 100 mL VISIPAQUE, POLY BTL 320MG/ML 100ML (10/CT) Compare Features Visipaque™ is a … Web29 nov. 2024 · Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography. CAS No. 92339-11-2 Purity & Quality Control Related Other Products Telaglenastat (CB-839) New Telaglenastat (CB-839) is a potent, selective, and orally bioavailable glutaminase inhibitor with IC50 of 24 nM for recombinant human … WebRegistered Medical Practitioner only. 1187820 IND IODIXANOL NAME OF THE MEDICINAL PRODUCT VISIPAQUE 150 mg I/ml, 270 mg I/ml, 320 mg I/ml QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient Strength Content pr. ml. Iodixanol (INN) 150 mg I/ml 305 mg equiv. 150 mg I Iodixanol (INN) 270 mg I/ml 550 mg equiv. … portland me white pages phone book